These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

428 related articles for article (PubMed ID: 18288338)

  • 1. A review of multidrug resistant surgical site infections.
    Weese JS
    Vet Comp Orthop Traumatol; 2008; 21(1):1-7. PubMed ID: 18288338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multidrug-resistant bacteria in hospitalized children: a 5-year multicenter study.
    Raymond J; Nordmann P; Doit C; Vu Thien H; Guibert M; Ferroni A; Aujard Y
    Pediatrics; 2007 Apr; 119(4):e798-803. PubMed ID: 17403822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Horizontal gene transfer-emerging multidrug resistance in hospital bacteria.
    Dzidic S; Bedeković V
    Acta Pharmacol Sin; 2003 Jun; 24(6):519-26. PubMed ID: 12791177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology and outcomes of multiple antibiotic-resistant bacterial infection in renal transplantation.
    Linares L; Cervera C; Cofán F; Ricart MJ; Esforzado N; Torregrosa V; Oppenheimer F; Campistol JM; Marco F; Moreno A
    Transplant Proc; 2007 Sep; 39(7):2222-4. PubMed ID: 17889144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiological and resistance issues in multidrug-resistant staphylococci and enterococci.
    Leclercq R
    Clin Microbiol Infect; 2009 Mar; 15(3):224-31. PubMed ID: 19335370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment options for multidrug-resistant bacteria.
    Giamarellou H
    Expert Rev Anti Infect Ther; 2006 Aug; 4(4):601-18. PubMed ID: 17009940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. "Collateral damage" from cephalosporin or quinolone antibiotic therapy.
    Paterson DL
    Clin Infect Dis; 2004 May; 38 Suppl 4():S341-5. PubMed ID: 15127367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pasteurization is effective against multidrug-resistant bacteria.
    Wang CY; Wu HD; Lee LN; Chang HT; Hsu YL; Yu CJ; Yang PC; Hsueh PR
    Am J Infect Control; 2006 Jun; 34(5):320-2. PubMed ID: 16765213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The challenge of multidrug resistance: the treatment of gram-negative rod infections.
    Levin AS; Oliveira MS
    Shock; 2008 Oct; 30 Suppl 1():30-3. PubMed ID: 18704012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical consequences of antimicrobial resistance.
    Rice LB
    Curr Opin Microbiol; 2009 Oct; 12(5):476-81. PubMed ID: 19716760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Incidence and sensitivity to antibiotics of germs isolated from surgical wound infections].
    Berceanu Văduva D; Moldovan R; Dumitraşcu V; Muntean D; Bădiţoiu L; Licker M; Crăciunescu M; Dan L; Branea D; Hogea E; Amăricăi E; Horhat F; Grigoraş D; Popa M; Berceanu Văduva M
    Bacteriol Virusol Parazitol Epidemiol; 2003; 48(2-3):123-9. PubMed ID: 15341326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in antibacterial therapy against emerging bacterial pathogens.
    Pournaras S; Iosifidis E; Roilides E
    Semin Hematol; 2009 Jul; 46(3):198-211. PubMed ID: 19549574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The growing burden of antimicrobial resistance.
    Hawkey PM
    J Antimicrob Chemother; 2008 Sep; 62 Suppl 1():i1-9. PubMed ID: 18684701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review of the guidelines for complicated skin and soft tissue infections and intra-abdominal infections--are they applicable today?
    Caínzos M
    Clin Microbiol Infect; 2008 Dec; 14 Suppl 6():9-18. PubMed ID: 19040462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgical site infections in spine surgery: identification of microbiologic and surgical characteristics in 239 cases.
    Abdul-Jabbar A; Berven SH; Hu SS; Chou D; Mummaneni PV; Takemoto S; Ames C; Deviren V; Tay B; Weinstein P; Burch S; Liu C
    Spine (Phila Pa 1976); 2013 Oct; 38(22):E1425-31. PubMed ID: 23873240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibiotic-resistant organisms in the neonatal intensive care unit.
    Bizzarro MJ; Gallagher PG
    Semin Perinatol; 2007 Feb; 31(1):26-32. PubMed ID: 17317424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro activity of tigecycline against resistant micro-organisms isolated from burn patients.
    Timurkaynak F; Arslan H; Azap OK; Senger SS; Başaran O; Karaman SO; Haberal M
    Burns; 2008 Nov; 34(7):1033-6. PubMed ID: 18539397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Infections caused by multiresistant bacteria].
    Zahar JR; Ferroni A
    Rev Prat; 2006 Sep; 56(13):1397-404. PubMed ID: 17002063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Phase 3, open-label, non-comparative study of tigecycline in the treatment of patients with selected serious infections due to resistant Gram-negative organisms including Enterobacter species, Acinetobacter baumannii and Klebsiella pneumoniae.
    Vasilev K; Reshedko G; Orasan R; Sanchez M; Teras J; Babinchak T; Dukart G; Cooper A; Dartois N; Gandjini H; Orrico R; Ellis-Grosse E;
    J Antimicrob Chemother; 2008 Sep; 62 Suppl 1():i29-40. PubMed ID: 18684704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multicenter study to assess the in vitro activity of tigecycline by disk diffusion test against clinical isolates from Argentina.
    Fernández Canigia L; Kaufman S; Lanata L; Vay C; Giovanakis M; Bantar C;
    Chemotherapy; 2009; 55(1):20-7. PubMed ID: 18974645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.